Clinical Trial Update: A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations

View source ↗

Summary

A completed clinical trial evaluating longitudinal plasma EBV DNA in nasopharyngeal carcinoma across endemic and non-endemic populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nasopharyngeal Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Mouth Cancer, Lip Cancer | Status: COMPLETED